Loss of p27 expression and microsatellite instability in sporadic colorectal cancer

Background: The role of the loss of p27 protein expression in the oncogenesis of colorectal cancer is still in debate. In this study, we prospectively examined the immunohistochemical expression of p27 in 108 consecutive colorectal cancers, and we analysed the relationship with the results, the clinicopathological data, microsatellite instability (MSI) and other genetic alterations of tumours. Methods: Unselected patients (108) who underwent curative colorectal resection for sporadic colorectal cancer in a three-year period were evaluated for MSI using 6 microsatellite markers, and for the presence of p27, p53, Fhit, Mth1 and Msh2 proteins by means of immunostaining. The relationships between these markers were analysed. p27 protein expression was examined for association with disease recurrences and survival. Results: Lack of p27 expression was noted in 33 out of 108 (30.5%) colorectal cancer cases (P < 0.05). This altered expression was significantly higher in proximal cancers (P < 0.05), mucinous tumours (P < 0.001), poorly differentiated histology (P < 0.01), cancers with MSI (P < 0.05), tumours with altered expression of Mth1 (P < 0.01), of Msh2 (P < 0.05), and of Fhit (P < 0.01). Overall survival was better in the patient group with altered level of phenotypic p27 expression, although the difference does not reach statistical significance (P=0.069). The analysis performed only for patients with tumour at stage 11 showed significantly better survival when the tumour exhibited altered p27 expression (P < 0.02). Conclusions: The results of the present study support the hypothesis that altered expression of p27 may be part of the genetic pathway involving MSI, which is responsible for the development of some colorectal cancers. (c) 2006 Elsevier Ltd. ALL rights reserved.